Theodore S. Johnson
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer (NCT05106296) | Theodore S. Johnson | 2022-02-08 |
| Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG (NCT04049669) | Theodore S. Johnson | 2019-10-02 |
Track Theodore S. Johnson automatically
Every clearance here is in the API, with alerts when new ones post.